| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.9M | +21.9% |
| Cost of Revenue | $2.1M | +9.2% |
| R&D Expense | $4.5M | -46.4% |
| SG&A Expense | $6.4M | -4.1% |
| Operating Income | -$10.2M | +31.0% |
| Net Income | -$9.7M | +25.5% |
| EPS (Basic) | -$0.34 | +27.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.8M | -63.2% |
| Accounts Receivable | $330K | +18.8% |
| Current Assets | $13.4M | -36.1% |
| Total Assets | $13.7M | -35.6% |
| Current Liabilities | $2.4M | -4.2% |
| Total Liabilities | $2.6M | -9.7% |
| Stockholders' Equity | $11.1M | -39.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.1M | +28.3% |
| Investing Cash Flow | -$2.4M | -145.4% |
| Financing Cash Flow | $544K | -55.8% |